Memory Test  Play Games
(exercise your mind)

  Researchers Identify Precursor to Alzheimer's

Jan. 16 (United States)  
 


Monday, January 16 (CogLabs Newswire)

Healthy individuals who are at risk of Alzheimer's disease show reduced activity in the hippocampal region of the brain when performing tasks related to forming new memories, according to US researchers.

The scientists observed that individuals carrying the apolipoprotein E (APOE) epsilon4 gene formation, which has previously been associated with high risk of developing Alzheimer's disease (AD), showed altered brain activity compared to APOE epsilon3 homozygotes.

According to the researchers, this supports the idea that certain regions of the brain exhibit functional decline associated with the AOPE epsilon4 gene formation, and this decline begins before the onset of AD symptoms.

In the study the participants were asked to distinguish between images that they were being shown for the first time and images that they had already memorized previously in a pre-scan training session.

During the task, the epsilon3/4 heterozygotes showed reduced activation in the medial temporal lobe of the brain (MTL), including the right hippocampus, compared to the epsilon3/3 homozygotes.

There were no differences between the two groups in age, education, performance during the task or neuropsychological assessment of memory; therefore the altered brain activation seen could not have been caused by impaired cognitive function.

According to the authors, "if compromised MTL function continues to be observed in healthy epsilon4 carriers, this group of subjects may represent a good study population for novel treatments designed to delay the onset or to prevent the development of AD".

The research was carried out by a team from the University of Wisconsin Medical School and the William S Middleton Memorial VA Hospital.

More information


Alzheimer's

Is there any treatment?

There is no cure for AD and no way to slow the progression of the disease. For some people in the early or middle stages of AD, medication such as tacrine (Cognex) may alleviate some cognitive symptoms. Donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl) may keep some symptoms from becoming worse for a limited time. A fifth drug, memantine (Namenda), was recently approved for use in the United States. Combining memantine with other AD drugs may be more effective than any single therapy. One controlled clinical trial found that patients receiving donepezil plus memantine had better cognition and other functions than patients receiving donepezil alone. Also, other medications may help control behavioral symptoms such as sleeplessness, agitation, wandering, anxiety, and depression. Prevention, through lifestyle changes and mental and physcial exercise, represents one of the best ways to reduce the likelihood of getting the disease, coupled with regular, systematic monitoring.  

What is the prognosis?

AD is a progressive disease, but its course can vary from 5 to 20 years. The most common cause of death in AD patients is infection.  As the population ages and other diseases are brought under control - Alzheimer's becomes a major risk.

What research is being done?


Scientists are currently studying or testing different types of drugs and other substances to determine if they can stop AD progression, including nonsteroidal anti-inflammatory drugs (NSAIDS), statins (such as those used for lowering cholesterol), folic acid, gingko biloba, huperzine, and vitamins E, B6, and B12. Studies in basic science are also exploring the potential of vaccines. Regular  'screenings' are being advocated by some - with the U.S. House of Representatives recently passing a bill in support of early memory check-ups.  All advocate a regimen of physical exercise and mental exercise. If you start an exercise regimen or just walking use MemCheck to track your progress.

Read testimonials from scientists and physicians on MemCheck.
  Give Memory For Life as a Gift for a loved one. Actions taken today help tomorrow.
Give the Gift of TV - Cognitive Labs and Microsoft are partnering on a special offer.

Source: NIH and Cognitive Advisors. For a qualified medical opinion or diagnosis, please see your healthcare provider.  

Famous People and Alzheimers: former President Ronald Reagan, Grambling University football coach Eddie Robinson, actor Charlton Heston, actor James Doohan.